All News

Approximately 46 percent of patients with breast cancer at high risk for recurrence but low genomic risk according to the 70-gene breast cancer recurrence assay (MammaPrint) might not require adjuvant chemotherapy.

Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for Hispanic men, rates have remained essentially unchanged. A new study suggests that lower rates of screening may be the driver of this disparity.

Learning to navigate breast cancer is easier with someone by your side.

Banding together with my large family had a positive effect not only on my brother, a patient, but on all of us.

The FDA has approved Blincyto (blinatumomab) for the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Women who are unable to travel to genetic counselors may be able to reap the same benefits over the phone, according to a recent study.

This dynamic suggests an important area of focus for oncologists and other health care professionals who provide care for the nation’s growing population of cancer survivors.

One of the methods my wife and I developed to ward of the cynicism that comes when faced with such an unrelenting foe is something we call "playing the cancer card."

Two-time cancer survivor suspects survivors look at the material stuff or clutter of life differently since their cancer diagnosis.

Nathalie LeVasseur, fellow at the Ottawa Hospital Cancer Centre, discusses diet in breast cancer survivors.